Page last updated: 2024-10-25

citalopram and Weight Loss

citalopram has been researched along with Weight Loss in 5 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Weight Loss: Decrease in existing BODY WEIGHT.

Research Excerpts

ExcerptRelevanceReference
" To compare changes in body weight during treatment with different antidepressants, body weight and height were measured at baseline and after 6, 8, 12 and 26 wk treatment with escitalopram or nortriptyline in 630 adults with moderate-to-severe unipolar depression participating in GENDEP, a part-randomized open-label study."5.15Changes in body weight during pharmacological treatment of depression. ( Aitchison, KJ; Dernovsek, MZ; Farmer, A; Gray, JM; Hauser, J; Henigsberg, N; Kalember, P; Keers, R; Kozel, D; Larsen, ER; Maier, W; McGuffin, P; Mendlewicz, J; Mors, O; Placentino, A; Rietschel, M; Souery, D; Strohmaier, J; Szczepankiewicz, A; Uher, R; Zobel, A, 2011)
"Citalopram is a new, highly selective inhibitor of 5HT re-uptake."2.67Treatment of severe obesity with a highly selective serotonin re-uptake inhibitor as a supplement to a low calorie diet. ( Elsborg, L; Szkudlarek, J, 1993)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boston, CD1
Wolter, H1
Schneider, N1
Pfeiffer, E1
Lehmkuhl, U1
Uher, R1
Mors, O1
Hauser, J1
Rietschel, M1
Maier, W1
Kozel, D1
Henigsberg, N1
Souery, D1
Placentino, A1
Keers, R1
Gray, JM1
Dernovsek, MZ1
Strohmaier, J1
Larsen, ER1
Zobel, A1
Szczepankiewicz, A1
Kalember, P1
Mendlewicz, J1
Aitchison, KJ1
McGuffin, P1
Farmer, A1
Szkudlarek, J1
Elsborg, L1
Bergh, C1
Eriksson, M1
Lindberg, G1
Södersten, P1

Trials

2 trials available for citalopram and Weight Loss

ArticleYear
Changes in body weight during pharmacological treatment of depression.
    The international journal of neuropsychopharmacology, 2011, Volume: 14, Issue:3

    Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Body Mass Index; Body Weight; Citalopram; Depressive

2011
Treatment of severe obesity with a highly selective serotonin re-uptake inhibitor as a supplement to a low calorie diet.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1993, Volume: 17, Issue:12

    Topics: Adolescent; Adult; Aged; Citalopram; Combined Modality Therapy; Diet, Reducing; Double-Blind Method;

1993

Other Studies

3 other studies available for citalopram and Weight Loss

ArticleYear
Competitive EDge or over the cliff?
    Journal of the Mississippi State Medical Association, 2013, Volume: 54, Issue:8

    Topics: Antidepressive Agents, Second-Generation; Citalopram; Depression; Fatigue; Humans; Hypercalcemia; Ma

2013
Diagnostic crossover from obesity to atypical anorexia nervosa - a case report.
    Obesity facts, 2009, Volume: 2, Issue:1

    Topics: Adolescent; Amenorrhea; Anorexia Nervosa; Antidepressive Agents, Second-Generation; Behavior Therapy

2009
Selective serotonin reuptake inhibitors in anorexia.
    Lancet (London, England), 1996, Nov-23, Volume: 348, Issue:9039

    Topics: Adolescent; Adult; Anorexia Nervosa; Antidepressive Agents; Child; Citalopram; Combined Modality The

1996